The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation

J Haerinck, S Goossens, G Berx - Nature Reviews Genetics, 2023 - nature.com
Epithelial–mesenchymal plasticity (EMP) enables cells to interconvert between several
states across the epithelial–mesenchymal landscape, thereby acquiring hybrid epithelial …

Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance

Z Guo, M Ashrafizadeh, W Zhang, R Zou… - Cancer and metastasis …, 2024 - Springer
The metastasis is a multistep process in which a small proportion of cancer cells are
detached from the colony to enter into blood cells for obtaining a new place for metastasis …

BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling

L Shaashua, A Ben-Shmuel, M Pevsner-Fischer… - Nature …, 2022 - nature.com
Tumors initiate by mutations in cancer cells, and progress through interactions of the cancer
cells with non-malignant cells of the tumor microenvironment. Major players in the tumor …

The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma

T Evan, VMY Wang, A Behrens - Oncogene, 2022 - nature.com
Intratumour heterogeneity (ITH) has become an important focus of cancer research in recent
years. ITH describes the cellular variation that enables tumour evolution, including tumour …

Transforming growth factor-Β blockade in pancreatic cancer enhances sensitivity to combination chemotherapy

L Qiang, MT Hoffman, LR Ali, JI Castillo, L Kageler… - Gastroenterology, 2023 - Elsevier
Background & Aims Transforming growth factor-b (TGFb) plays pleiotropic roles in
pancreatic cancer, including promoting metastasis, attenuating CD8 T-cell activation, and …

Epigenetic control of pancreatic cancer metastasis

L Krauß, C Schneider, E Hessmann, D Saur… - Cancer and Metastasis …, 2023 - Springer
Surgical resection, when combined with chemotherapy, has been shown to significantly
improve the survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) …

The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: Unravelling challenges and opportunities

M Herpels, J Ishihara… - The Journal of …, 2023 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of
pancreatic cancer and has abysmal survival rates. In the past two decades …

Targeted Cyclo [8] pyrrole-Based NIR-II Photoacoustic Tomography Probe for Suppression of Orthotopic Pancreatic Tumor Growth and Intra-abdominal Metastases

J Chen, R Chen, CV Chau, AC Sedgwick… - Journal of the …, 2024 - ACS Publications
Pancreatic cancer is highly lethal. New diagnostic and treatment modalities are desperately
needed. We report here that an expanded porphyrin, cyclo [8] pyrrole (CP), with a high …

Epithelial to mesenchymal transition as mechanism of progression of pancreatic cancer: from mice to men

L Greco, F Rubbino, L Laghi - Cancers, 2022 - mdpi.com
Simple Summary The progression of pancreatic cancer (PDAC) involves a series of events
transforming the phenotype of cancer cells, namely epithelial-to-mesenchymal transition …

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

RR Tindall, JM Bailey-Lundberg, Y Cao… - Frontiers in Oncology, 2024 - frontiersin.org
The transforming growth factor (TGF)-β superfamily has important physiologic roles and is
dysregulated in many pathologic processes, including pancreatic cancer. Pancreatic cancer …